Hematoma Resorption in Intracerebral Hemorrhage: A Translational Overview on Pathophysiology, Biomarkers, and Innovative Therapies
Translational Stroke Research · 2025-12 · 16 (6) · 2350-2363
DOI: 10.1007/s12975-025-01389-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Stroke Research, online erschienen am 11.10.2025. Verfasst von Laurent Puy und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, F-59000, France. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Hematoma, Translational Research, Biomedical. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben.
Abstract (Originalsprache)
Spontaneous intracerebral hemorrhage (ICH) is a severe cerebrovascular condition with limited therapeutic options. One of the major contributors to ICH pathophysiology and secondary brain injury is the toxicity of blood products. As a result, removing parenchymal blood has emerged as a potential strategy to reduce mortality and improve patient outcomes. While minimally invasive surgical techniques have shown promising results, their broader application is limited by stringent patient selection criteria and technical challenges. Consequently, a pharmacological approach aiming at modulating the endogenous clearance of blood is of particular interest. Recent advances, from experimental models to human studies, have enhanced our understanding of the mechanisms involved in spontaneous hematoma resorption, leading to the identification of several biomarkers and potential therapeutic targets. This narrative review takes a translational approach to provide an update on the current knowledge of hematoma resorption, including its natural history, underlying mechanisms, and associated imaging and biological biomarkers. Special focus will be given to the most promising pharmacomodulatory strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, F-59000, France.
- Neurology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.
- SC Neurology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
- SC Neurology, Department of Continuity of Care and Frailty, ASST Spedali Civili Hospital, Brescia, Italy.
- Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Zitieren
APA
Puy, L., Mazzoleni, V., Samarasekera, N., Morotti, A., Tsai, H. H., Gaberel, T., Cordonnier, C., & Bérézowski, V. (2025). Hematoma Resorption in Intracerebral Hemorrhage: A Translational Overview on Pathophysiology, Biomarkers, and Innovative Therapies. Translational Stroke Research, 16(6), 2350-2363. https://doi.org/10.1007/s12975-025-01389-3
Vancouver
Puy L, Mazzoleni V, Samarasekera N, Morotti A, Tsai HH, Gaberel T, et al. Hematoma Resorption in Intracerebral Hemorrhage: A Translational Overview on Pathophysiology, Biomarkers, and Innovative Therapies. Translational Stroke Research. 2025;16(6):2350-2363. doi:10.1007/s12975-025-01389-3
BibTeX
@article{Puy2025,
author = {Puy, Laurent and Mazzoleni, Valentina and Samarasekera, Neshika and Morotti, Andrea and Tsai, Hsin-Hsi and Gaberel, Thomas and Cordonnier, Charlotte and Bérézowski, Vincent},
title = {Hematoma Resorption in Intracerebral Hemorrhage: A Translational Overview on Pathophysiology, Biomarkers, and Innovative Therapies},
journal = {Translational Stroke Research},
year = {2025},
volume = {16},
number = {6},
pages = {2350--2363},
doi = {10.1007/s12975-025-01389-3}
}
EUVIMED